Length of the antibody heavy chain complementarity determining region 3 as a specificity‐determining factor
- 14 May 2004
- journal article
- research article
- Published by Wiley in Journal of Molecular Recognition
- Vol. 17 (4) , 332-338
- https://doi.org/10.1002/jmr.679
Abstract
The antigen binding site of an antibody is made up of residues residing in six hypervariable loops of the heavy and light chains. In most cases several or all of these loops are required for the establishment of the antigen‐binding surface. Five of these loops display a limited diversity in length and sequence while the third complementarity determining region (CDR) of the heavy chain is highly different between antibodies not only with respect to sequence but also with respect to length. Its extensive diversity is a key component in the establishment of binding sites allowing for the recognition of essentially any antigen by humoral immunity. The relative importance of its sequence vs its length diversity in this context is however, not very well established. To investigate this matter further we have used an approach employing combinatorial antibody libraries and antigen‐specific selection in the search for CDRH3 length and sequence diversity compatible with a given antigen specificity, the major antigenic determinant on the tumour‐associated antigen mucin‐1. In this way we have now defined heavy chain CDR3 length as a critical parameter in the creation of an antigen‐specific binding site. We also propose that this may reflect a dependence of a particular structure of this hypervariable loop, the major carrier of diversity in the binding site, for establishment of a given specificity. Copyright © 2004 John Wiley & Sons, Ltd.Keywords
This publication has 28 references indexed in Scilit:
- Expressed Murine and Human CDR-H3 Intervals of Equal Length Exhibit Distinct Repertoires that Differ in their Amino Acid Composition and Predicted Range of StructuresPublished by Elsevier ,2003
- Antibody evolution beyond NatureNature Biotechnology, 2002
- Antibody Evolution from the Centre to the Periphery: Applied to a Human Antibody Fragment Recognising the Tumour-associated Antigen Mucin-1Journal of Molecular Biology, 2002
- Summary Report on the ISOBM TD-4 Workshop: Analysis of 56 Monoclonal Antibodies against the MUC1 MucinTumor Biology, 1998
- Conformations of the third hypervariable region in the VH domain of immunoglobulins 1 1Edited by I. A. WilsonJournal of Molecular Biology, 1998
- Standard conformations for the canonical structures of immunoglobulins 1 1Edited by I. A. WilsonJournal of Molecular Biology, 1997
- The human immunoglobulin VH repertoireImmunology Today, 1995
- Restricted variable region gene usage and possible rheumatoid factor relationship among human monoclonal antibodies specific for the AD-1 epitope on cytomegalovirus glycoprotein BMolecular Immunology, 1994
- Phage antibodies: filamentous phage displaying antibody variable domainsNature, 1990
- Filamentous Fusion Phage: Novel Expression Vectors That Display Cloned Antigens on the Virion SurfaceScience, 1985